Bristol Myers Squibb to Participate in Upcoming Investor Conferences
2024年11月6日 - 7:00AM
ビジネスワイヤ（英語）
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will participate in two upcoming investor conferences in
November 2024.
Samit Hirawat, M.D., Executive Vice President, Chief Medical
Officer and Head of Development, and Robert Plenge, M.D., Ph.D.,
Executive Vice President, Chief Research Officer, will take part in
a fireside chat at Guggenheim’s Inaugural Healthcare Innovation
Conference. They will answer questions about the company beginning
at 10:00 a.m. ET on November 11, 2024.
David Elkins, Executive Vice President, Chief Financial Officer,
will participate in a fireside chat at the 2024 Jefferies London
Healthcare Conference on November 19, 2024. He will answer
questions about the company beginning at 9:30 a.m. GMT (U.K.).
Investors and the general public are invited to listen to both
sessions at their respective times by visiting
http://investor.bms.com. An archived edition of each session will
be available following its conclusion.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, X (formerly Twitter), YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241105721845/en/
Media: media@bms.com Investors:
investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
過去 株価チャート
から 10 2024 まで 11 2024
Bristol Myers Squibb (NYSE:BMY)
過去 株価チャート
から 11 2023 まで 11 2024
